化学
荧光
疾病
生物标志物
鉴定(生物学)
诊断生物标志物
临床诊断
计算生物学
纳米技术
医学
病理
重症监护医学
生物化学
材料科学
生物
量子力学
物理
植物
作者
Xin Wang,Qi Ding,Robin R. Groleau,Luling Wu,Yuantao Mao,Feida Che,Oxana Kotova,Eoin M. Scanlan,Simon E. Lewis,Ping Li,Bo Tang,Tony D. James,Thorfinnur Gunnlaugsson
出处
期刊:Chemical Reviews
[American Chemical Society]
日期:2024-05-17
卷期号:124 (11): 7106-7164
被引量:11
标识
DOI:10.1021/acs.chemrev.3c00776
摘要
The identification and detection of disease-related biomarkers is essential for early clinical diagnosis, evaluating disease progression, and for the development of therapeutics. Possessing the advantages of high sensitivity and selectivity, fluorescent probes have become effective tools for monitoring disease-related active molecules at the cellular level and in vivo. In this review, we describe current fluorescent probes designed for the detection and quantification of key bioactive molecules associated with common diseases, such as organ damage, inflammation, cancers, cardiovascular diseases, and brain disorders. We emphasize the strategies behind the design of fluorescent probes capable of disease biomarker detection and diagnosis and cover some aspects of combined diagnostic/therapeutic strategies based on regulating disease-related molecules. This review concludes with a discussion of the challenges and outlook for fluorescent probes, highlighting future avenues of research that should enable these probes to achieve accurate detection and identification of disease-related biomarkers for biomedical research and clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI